The Charismatic Charlie Wade novel Chapter 3709

Chapter 3709

After Charlie and Qinghua said goodbye to each other on the phone, Issac also drove his car to the entrance of Classic Mansion.

Along with Orvel, the general manager of JX Pharmaceutical, Liang, came out to greet him.

When he saw Charlie, Liang hurriedly and respectfully came forward and said, "Master Wade!"

Charlie did not expect Liang to come so quickly, and could not help but laugh: "How did you get here so quickly?"

Liang said, "Mr. Issac said you were looking for me for something, so I rushed over."

Charlie nodded and smiled: "Looking for you to talk about the new drug, come in let's talk."

Orvel hurriedly said, "Master Wade, the diamond box is ready, please!"

Charlie then said, "Let's all join together."

Several people came to the diamond box with Charlie, and after they were seated, he asked Liang straight to the point: "How is the recent business situation of the company?"

Liang could not hide his excitement and said, "Master Wade, our JX Weisan is selling very well now, and has successfully entered the markets of some developed countries in Europe and the Americas, with global monthly sales of more than two billion RMB, and it is rising.

Charlie didn't feel much when he heard this data, instead, Issac was shocked and asked, "The global sales of JX Weisan alone exceeded two billion RMB in one month?"

Liang laughed: "Mr. Issac, this is only half of the situation in developed countries in Europe and the United States,"

"You know, JX Weisan in overseas, no matter which country's currency, the actual pricing converted into U.S. dollars exchange rate, is about one hundred U.S. dollars, equivalent to about six hundred yuan,"

"This deducts the production costs, tariffs, and corporate income tax, and then deduct the channel costs, publicity The net profit is about forty to fifty percent."

Issac could not help but exclaim: "If all the European and American countries are taken, won't it be possible to double?"

"Yes." Liang explained, "In many countries of Europe and in the United States for overseas import drug approval is relatively strict, need US to produce relatively complete pharmacological experiments as well as clinical trial data, and even pharmacokinetics."

"These also require US to give detailed data, the most headache is that they need US to have to publish the prescription, this we are still negotiating with the relevant local agencies."

Charlie said lightly: "JX Pharmaceutical's prescription, is absolutely impossible to leak out, this they do not even have to think about."

Liang said with more or less difficulty: "But Master Wade.............. if the other side insists, if we do not agree, the other side will not approve our drugs to be marketed in their country."

Charlie asked rhetorically, "Is there nothing special about this kind of policy?"

"There is...... " Liang explained: "If it is a high mortality rate of major disease-related special drugs, some cases are able to get special approval,"

"But that is basically some for cancer, cardiovascular disease Similar to these high mortality rate of serious illnesses, or for diabetes, a chronic disease that requires long­term medication,"

"If there are special drugs in these areas, they will generally open an opening to let the drug in first."